FDA News Digest
November 3, 2003
________________________________________________

FDA Draft Assessment Indicates Food from Animal Clones Is Safe

FDA has released a summary of a draft assessment stating that food from
animal clones and their offspring is likely to be as safe as that from
non-clones.  The assessment is part of an ongoing review of scientific
evidence regarding the safety of food products derived from animal clones.
Studies have shown that healthy adult clones are virtually indistinguishable
from their conventional counterparts.
http://www.fda.gov/bbs/topics/NEWS/2003/NEW00968.html
_____________________________________________________________

FDA Warns Doctors About Side Effects of Drug-Coated Stent

FDA has advised doctors of reports the agency has received linking the
Cordis Corp. Cypher Coronary Stent to more than 60 deaths and more than 200
serious adverse effects. The stent is a tiny mesh cylinder coated with a
slow-release drug that is implanted in clogged coronary arteries after the
vessels are opened by angioplasty.
http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01257.html
______________________________________________________________

Agency Advises Doctors About Possible Link Between
Antidepressants and Suicide Potential in Children

FDA is advising medical professionals that the agency has received reports
of suicidal thinking and suicidal attempts in pediatric patients involved in
clinical studies of several antidepressants administered to treat major
depressive disorder.  Though studies of the drugs to date have shown no
definitive link to suicide potential, FDA officials say this possibility
cannot be ruled out.
http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01256.html
______________________________________________________________

New Food Tests Help Protect Those with Deadly Peanut Allergy

FDA has collaborated with the Association of Official Analytical Chemists to
approve several testing methods for detecting peanuts in foods such as
breakfast cereal, cookies and ice cream. The tests will allow the food
industry to determine if peanuts are present in foods not labeled as
containing peanuts, an important advance because peanuts can cause serious
allergic reactions in some people.
http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01258.html
______________________________________________________________

FDA Calls Steroid Alternative THG an Unapproved Drug

FDA has determined that the substance tetrahydrogestrinone (THG), sometimes
marketed as a dietary supplement and reportedly used as a steroid
alternative to improve athletic performance, is an unapproved drug that is
potentially harmful. As such, it cannot be marketed legally without FDA's
formal approval.
http://www.fda.gov/bbs/topics/NEWS/2003/NEW00967.html
______________________________________________________________

RECALLS

The following products are being recalled for the reasons shown. Go to the
linked page for more information.

Uncle Charlie's Apricot Muffin Mix (undeclared sulfites)
http://www.fda.gov/oc/po/firmrecalls/unclecharlie10_03.html

Daifuku Trading Corp. Kasugai/Rakka Senbei (Japanese cookies) (undeclared
peanuts)
http://www.fda.gov/oc/po/firmrecalls/Daifuku10_03.html

Hegedorn's Supermarket Sugar-Free Golden Pound Cake (undeclared milk)
http://www.fda.gov/oc/po/firmrecalls/poundcake10_03.html

For an archive of FDA-related recalls and safety alerts from the last 60
days, go to http://www.fda.gov/opacom/7alerts.html
______________________________________________________________

RECENT TESTIMONY

FDA Associate Commissioner for Regulatory Affairs John M. Taylor, before the
Senate Committee on Commerce (Oct. 28)
http://www.fda.gov/ola/2003/dietarysupplements1028.html

For an archive of testimony by FDA officials, go to
http://www.fda.gov/ola/listing.html
______________________________________________________________

PUBLIC MEETINGS

Nov. 4 -- Veterinary Medicine Advisory Committee; Rockville, Md.
http://www.fda.gov/oc/advisory/accalendar/cvm12548ddd1103040503amd.html

Nov. 12 -- FDA Public Workshop on Clinical Trial Endpoints in Colorectal
Cancer; Washington, D.C.
http://www.fda.gov/cder/drug/cancer_endpoints/colonAnnouncement.pdf

Nov. 20 -- FDA Workshop: Exploring the Link Between Food Labeling and Weight
Management; Bethesda, Md.
https://secure.z-techcorp.com/cmt/meetings/meeting_detail.cfm?meeting_id=26

For a list of upcoming FDA meetings, seminars, and other public events, go
to
http://www.fda.gov/opacom/hpmeetings.html.
______________________________________________________________

Thanks for subscribing to FDA News Digest. Our next posting will be
November 10.

To leave this list at any time, send an e-mail to
[EMAIL PROTECTED]
In the body of the message, write
SIGNOFF FDA-NEWSDIGEST-L

Reply via email to